Keisuke Yamamura

Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models

Nozomu Tanaka, Kazuki Sakamoto, Hiroyuki Okabe et al. · Oncology Reports · 2014 · 142 citations · Full text

Medicine, Oncology, Pharmacology +13

1,2,3-Triazole-Containing Uracil Derivatives with Excellent Pharmacokinetics as a Novel Class of Potent Human Deoxyuridine Triphosphatase Inhibitors

Hitoshi Miyakoshi, Seiji Miyahara, Tatsushi Yokogawa et al. · Journal of Medicinal Chemistry · 2012 · 56 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA‐repair‐defective human cancer cells

Tatsushi Yokogawa, Wakako Yano, Sayaka Tsukioka et al. · Cancer Science · 2020 · 41 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Discovery of a Novel Class of Potent Human Deoxyuridine Triphosphatase Inhibitors Remarkably Enhancing the Antitumor Activity of Thymidylate Synthase Inhibitors

Seiji Miyahara, Hitoshi Miyakoshi, Tatsushi Yokogawa et al. · Journal of Medicinal Chemistry · 2012 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +11

Influence of various superhydrophilic treatments of titanium on the initial attachment, proliferation, and differentiation of osteoblast-like cells

Keisuke Yamamura, Tadashi Miura, I KOU et al. · Dental Materials Journal · 2015 · 32 citations · Full text

Medicine, Biomedical Engineering, Materials Science +17